NRX Pharmaceuticals (NRXP) Tax Rate (2018 - 2024)

NRX Pharmaceuticals (NRXP) posted quarterly Tax Rate of 0.1% for Q3 2024, down 938.09% quarter-over-quarter from 0.01% in Q4 2020.

NRX Pharmaceuticals (NRXP) Tax Rate (2018 - 2024) Analysis & Trends

NRX Pharmaceuticals (NRXP) has reported Tax Rate for 4 consecutive years, with 0.1% the latest figure, recorded in Q3 2024.

In Q3 2024, Tax Rate changed N/A year-over-year to 0.1%; the TTM figure through Sep 2025 stood at 0.02% (down 1.0% YoY), while the FY2020 annual figure was 0.03%, down 2081.0% from the prior year.
Tax Rate slipped to 0.1% in Q3 2024 per NRXP's latest filing, from 0.01% in the prior quarter.
Across five years, Tax Rate topped out at 21.0% in Q1 2020 and bottomed at 6.59% in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	15.11%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	10.91%
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	7.49%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-16.71%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	34.12%
10	NRX Pharmaceuticals	132.53 Mn	105.83 Mn	426,000.00	-

Download Data